Résultats de la recherche - Angela Panoskaltsis‐Mortari
- Résultat(s) 1 - 20 résultats de 100
- Aller à la page suivante
-
1
3D bioprinting for lungs and hollow organs par Zachary Galliger, Caleb Vogt, Angela Panoskaltsis‐Mortari
Publié 2019Revisão -
2
-
3
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility co... par BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, GS Gray, DA Vallera
Publié 1995Artigo -
4
-
5
-
6
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines par Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Daniel A. Vallera
Publié 1998Artigo -
7
-
8
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy par Daniel A. Vallera, Hua Chen, Andrew R. Sicheneder, Angela Panoskaltsis‐Mortari, Elizabeth Taras
Publié 2009Artigo -
9
-
10
Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells par Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Arlene H. Sharpe, Daniel A. Vallera
Publié 1999Artigo -
11
-
12
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations par Michael Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Publié 2008Artigo -
13
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients par Bruce R. Blazar, Byoung S. Kwon, Angela Panoskaltsis‐Mortari, Kyu B. Kwak, Jacques J. Peschon, Patricia A. Taylor
Publié 2001Artigo -
14
-
15
Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging par Dullei Min, Angela Panoskaltsis‐Mortari, Makoto Kuro‐o, Georg A. Holländer, Bruce R. Blazar, Kenneth I. Weinberg
Publié 2006Artigo -
16
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality par Lisa K. Jasperson, Christoph Bucher, Angela Panoskaltsis‐Mortari, Andrew L. Mellor, David H. Munn, Bruce R. Blazar
Publié 2009Artigo -
17
CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or... par Bruce R. Blazar, Patricia A. Taylor, Michael W. Boyer, Angela Panoskaltsis‐Mortari, James P. Allison, Daniel A. Vallera
Publié 1997Artigo -
18
-
19
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. par Bruce R. Blazar, Arlene H. Sharpe, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, G S Gray, Robert Korngold, Daniel A. Vallera
Publié 1996Artigo -
20
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients par Patricia A. Taylor, Michael Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Bruce R. Blazar
Publié 2006Artigo
Outils de recherche:
Sujets similaires
Immunology
Biology
Medicine
Internal medicine
Immune system
Graft-versus-host disease
Cancer research
Biochemistry
T cell
Cell biology
Transplantation
In vitro
Stem cell
Genetics
Cytotoxic T cell
Pathology
Receptor
Disease
CD8
Bone marrow
Lung
Antibody
Antigen
Chemistry
Leukemia
Cytokine
Gene
Chemotherapy
Inflammation
Adoptive cell transfer